Third Rock Ventures Ii, L.P. is > 10% Shareholder of Allena Pharmaceuticals, Inc.. Currently has a direct ownership of 2.79 Million shares of ALNA, which is worth approximately $27,909. The most recent transaction as insider was on Nov 06, 2017, when has been sold 215,000 shares (Common Stock) at a price of $14.0 per share, resulting in proceeds of $3,010,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.79M
0% 3M change
0% 12M change
Total Value Held $27,909

Third Rock Ventures II, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 06 2017
BUY
Open market or private purchase
$3,010,000 $14.0 p/Share
215,000 Added 7.15%
2,790,964 Common Stock
Nov 06 2017
BUY
Conversion of derivative security
-
2,575,964 Added 50.0%
2,575,964 Common Stock

Also insider at

MYOK
MyoKardia Inc
JNCE
Jounce Therapeutics, Inc. Healthcare
RVMD
Revolution Medicines, Inc. Healthcare
TRV

Third Rock Ventures Ii, L.P.

> 10% Shareholder
Boston, MA

Track Institutional and Insider Activities on ALNA

Follow Allena Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALNA shares.

Notify only if

Insider Trading

Get notified when an Allena Pharmaceuticals, Inc. insider buys or sells ALNA shares.

Notify only if

News

Receive news related to Allena Pharmaceuticals, Inc.

Track Activities on ALNA